• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Mylan agrees to settle SEC EpiPen probe for $30 million

July 31, 2019 By Nancy Crotti

Mylanepipen (NSDQ:MYL) is nearing a $30 million settlement with the Securities and Exchange Commission (SEC) over an investigation involving the company’s EpiPen auto-injector and the Medicaid drug rebate program.

The SEC probe was announced in 2016, shortly after Mylan agreed to pay $465 million to the U.S. Department of Justice to settle claims that it underpaid Medicaid for EpiPen by misclassifying the device as a generic. The Centers for Medicare and Medicaid Services reported in 2016 that it spent $797 million on the EpiPen between 2011 and 2015, including rebates. 

Mylan said in a regulatory filing today that it had reached an agreement in principle with the SEC’s enforcement division to pay the $30 million without admitting or denying the allegations. The SEC must approve the settlement before it becomes final, Mylan said.

Reports surfaced in 2016 that Mylan raised the price of EpiPen by more than 500% over the previous decade. The controversy spurred Mylan and other companies to launch generic versions of the device, used to halt severe allergic reactions.

Filed Under: Auto-injectors, Business/Financial News, Legal News, Wall Street Beat Tagged With: Centers for Medicare and Medicaid Services (CMS), epipen, Mylan, Securities and Exchange Commission (SEC), U.S. Department of Justice

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS